Skip to content
OpenCapital
Get started
Income StatementBalance SheetCash FlowSegments
Ameriprise Financial logo

Ameriprise Financial Cash Flow Statement

Operating, investing, and financing cash movements

Ameriprise Financial generated $7.1B in operating cash flow over the trailing twelve months. After $155.0M in capital expenditures, free cash flow was $6.9B. Free cash flow increased 0.0% year-over-year. Based on the Q1 2026 filing.

Net Cash From Operating (TTM)$7.1BNet Cash From Investing (TTM)-$6.7BNet Cash From Financing (TTM)-$6.2BCapital Expenditures (TTM)$155.0MDepreciation And Amortization Cf (TTM)-$75.0MNet Change In Cash (TTM)$434.0M
Latest FilingQ1 2026
Report Date2026-05-07
Market Cap$40.5B
P/E Ratio10.39
ROE66.94%

Investing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Capital expenditures$58M$36M$38M$44M$44M$29M
Increase Decrease Of Restricted Investments-$104M-$158M-$319M——$0
Payment to Acquire Investments by Consolidated Investment Entities$334M$354M$377M$333M$367M$259M
Payments For Derivative Instrument Investing Activities—$0$0$0$50M$73M
Payments for Other Deposits$8M$8M$7M$7M$7M$7M
Payment for (Proceeds from) Other Investing Activity$49M$10M$39M$34M$323M$26M
Payments to Acquire Mortgage Notes Receivable$104M$107M$133M$210M$263M$207M
Payments to Acquire Other Investments$5M$26M$15M$6M$4M$3M
Proceeds From Derivative Instrument Investing Activities—$0$5M$0$15M$18M
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale$4.5B$4.2B$4.3B$4.6B$3.9B$2.9B
Proceeds from short-term investment in time deposit$122M$112M$117M$101M$97M$97M
Proceeds from Sale and Collection of Mortgage Notes Receivable$47M$37M$49M$67M$87M$111M
Sale of investments$530M$1.1B$498M$328M$253M$602M
Proceeds from sales, maturities and repayments of investments by consolidated investment entities$417M$167M$259M$237M$325M$245M
Net cash from investing activities-$783M-$1.7B—$1B-$1.6B-$669M
Proceeds from maturities/sales of investments$21M$22M$29M$10M$9M$13M
Purchases of investments$5.9B$6.8B$3.8B$3.7B$5.2B$4.1B

Operating

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Change in accounts payable$132M-$452M——$288M-$467M
Change in income taxes payable/receivable$26M$180M-$593M——$240M
Other working capital changes—-$293M—-$184M—-$308M
Change in receivables$0$220M—$348M—$269M
Deferred income taxes—-$95M$202M$80M—-$19M
Depreciation and amortization-$34M-$27M-$27M-$19M-$20M-$9M
Net gains (losses) on investments$2M$1M$1M$2M$2M$1M
Net cash from operating activities$383M$1.7B$1.8B$2.2B$2.7B$459M
Net income$1.1B$583M$1.1B$912M$1B$915M
Change in Other Operating Assets and Liabilities of Consolidated Investment Entities$0-$2M-$5M—-$1M$7M
Consolidated Investment Entities Unrealized Realized Gain (Loss) on Assets and Liabilities$18M-$12M——-$8M-$9M
Derivatives, net of collateral-$528M$270M-$545M-$572M—-$1B
Gain (Loss) on Sale of Investments-$15M$5M-$15M$11M$2M$0
Equity in earnings (losses) of equity method investees-$6M-$13M——-$5M-$6M
Brokerage deposits-$300M-$25M-$121M-$69M-$170M$14M
Increase (Decrease) in Deferred Policy Acquisition Costs-$9M-$16M-$14M-$13M-$9M-$13M
Impairments and provision for loan and credit losses$4M-$5M$1M$11M$12M-$1M
Stock-based compensation$55M$49M$46M$50M$61M$39M

Financing

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Repayments of debt$553M$3M$503M$2M$2M$0
Dividends paid$144M$144M$152M$151M$149M$148M
Policyholder contract deposits$376M$254M$336M$377M$326M$266M
Borrowings of consolidated investment entities$390M$304M$387M$126M$303M$0
Increase (Decrease) in Deposits$576M$363M—$95M$1.1B$109M
Proceeds from additions$1.1B$961M$791M$695M$617M$586M
Investment Certificates and Banking Time Deposits Maturities Withdrawals and Cash Surrenders$1.9B$1.5B$1.6B$1.7B$1.4B$1.2B
Payments For Derivative Instrument Financing Activities$26M$3M$37M$31M$50M$55M
Net transfers from (to) separate accounts$300M-$36M-$35M-$47M$281M-$39M
Proceeds From Derivative Instrument Financing Activities$48M$0$0$46M$50M$110M
Proceeds from new debt$0$740M——$1M$0
Repayments of Debt of Consolidated Investment Entities$226M$328M$34M$256M$304M$1M
Withdrawal from Contract Holders Funds$380M$395M$356M$359M$377M$327M
Net cash from financing activities-$1.5B-$488M-$1.9B-$1.9B-$871M-$1.5B
Repurchases of common stock$665M$730M$581M$701M$895M$874M

Free Cash Flow

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Free cash flow$325M$1.7B$1.7B$2.2B$2.6B$430M

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Effect of exchange rate changes on cash-$32M$13M$25M—$1M-$9M
Net increase (decrease) in cash—-$530M$651M$1.3B$206M-$1.8B
Leased assets obtained in exchange for operating lease liabilities$16M$22M$12M$8M$8M$11M

Supplemental

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Health care costs payable and other insurance liabilities$386M$940M$1.2B$1.6B$829M$728M